Literature DB >> 30843179

Glycosylation of thyroid-stimulating hormone receptor.

Paulina Korta1, Ewa Pocheć2.   

Abstract

Thyroid-stimulating hormone receptor (TSHR) is a typical membrane receptor with 7-transmembrane helix domain (7TMR), coupled to the G protein. The mature receptor, present in the cell membrane, is composed of the A subunit comprising a large extracellular domain, and the B subunit, which consists of a short extracellular fragment anchored in the cell membrane and an intracellular part. The TSH receptor is subject to numerous post-translational modifications that determine its final structure and significantly affect its activity. One of them is glycosylation. TSHR is abundantly N-glycosylated, due to the presence of six N-glycosylation sites in the extracellular domain (Asn77, Asn99, Asn113, Asn177, Asn198, Asn302), mostly evolutionarily conserved. N-glycans constitute 30-40% of the receptor molecular weight. The glycans are necessary for the receptor trafficking to the plasma membrane and binding of TSH to the receptor. Fucosylated and sialylated N-oligosaccharides were found on TSHR molecules. The increased sialylation of TSHR glycans correlates positively with the receptor binding ability and prolongs the time of receptor incorporation into the cell membrane. TSHR is the main autoantigen in Graves' disease (GD), one of the thyroid autoimmune diseases. One hypothesis assumes that the higher N-glycosylation of THSR in human compared to animals influences the breaking of autotolerance and GD development. N-oligosaccharides are the important part of THSR molecule, necessary for the proper functioning of receptors and probably involved in thyroid autoimmunity in GD.

Entities:  

Keywords:  Graves’ disease; N-glycosylation; TSHR; sialylation; thyroid

Mesh:

Substances:

Year:  2019        PMID: 30843179     DOI: 10.5603/EP.a2018.0077

Source DB:  PubMed          Journal:  Endokrynol Pol        ISSN: 0423-104X            Impact factor:   1.582


  6 in total

1.  Glycosylation in Autoimmune Diseases.

Authors:  Marta Ząbczyńska; Paweł Link-Lenczowski; Ewa Pocheć
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 3.650

2.  Superiority of the Non-Glycosylated Form Over the Glycosylated Form of Irisin in the Attenuation of Adipocytic Meta-Inflammation: A Potential Factor in the Fight Against Insulin Resistance.

Authors:  Agnieszka Irena Mazur-Bialy
Journal:  Biomolecules       Date:  2019-08-21

Review 3.  Irisin as a Multifunctional Protein: Implications for Health and Certain Diseases.

Authors:  Paulina Korta; Ewa Pocheć; Agnieszka Mazur-Biały
Journal:  Medicina (Kaunas)       Date:  2019-08-15       Impact factor: 2.430

Review 4.  FNDC5/Irisin: Physiology and Pathophysiology.

Authors:  Rashid Waseem; Anas Shamsi; Taj Mohammad; Md Imtaiyaz Hassan; Syed Naqui Kazim; Anis Ahmad Chaudhary; Hassan Ahmed Rudayni; Mohammed Al-Zharani; Faizan Ahmad; Asimul Islam
Journal:  Molecules       Date:  2022-02-08       Impact factor: 4.411

5.  Genome-Wide Association Analysis and Genomic Prediction of Thyroglobulin Plasma Levels.

Authors:  Nikolina Pleić; Mirjana Babić Leko; Ivana Gunjača; Thibaud Boutin; Vesela Torlak; Antonela Matana; Ante Punda; Ozren Polašek; Caroline Hayward; Tatijana Zemunik
Journal:  Int J Mol Sci       Date:  2022-02-16       Impact factor: 5.923

Review 6.  Intrathyroidal feedforward and feedback network regulating thyroid hormone synthesis and secretion.

Authors:  Li Jing; Qiang Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-15       Impact factor: 6.055

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.